Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Communications Chemistry|July 1, 2024
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growingMinh Sai, Emily C Hank, Hin-Man Tai, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 ModulatorsAlisa Lang, Tanja Stiller, Niklas Ildefeld, et al.
Journal of Medicinal Chemistry|July 17, 2025
Carboxylic Acid Bioisosteres Boost Nurr1 Agonist SelectivityTanja Stiller, Christian Gege, Wael Saeb, et al.
Bioorganic Chemistry|September 26, 2022
Fragment-based discovery of orphan nuclear receptor Nur77/NGFI-B ligandsSilvia Arifi, Daniel Zaienne, Jan Heering, et al.
Food & Function|December 23, 2022
State-of-the-art methodological investigation of carotenoid activity and metabolism - from organic synthesis <i>via</i> metabolism to biological activity - exemplified by a novel retinoid signalling pathwayTorsten Bohn, Angel R de Lera, Jean-Francois Landrier, et al.
Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.
Journal of Medicinal Chemistry|September 4, 2020
Photohormones Enable Optical Control of the Peroxisome Proliferator-Activated Receptor γ (PPARγ)Konstantin Hinnah, Sabine Willems, Johannes Morstein, et al.
Bioorganic & Medicinal Chemistry|May 3, 2015
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like propertiesDaniel Flesch, Matthias Gabler, Andreas Lill, et al.
ACS Medicinal Chemistry Letters|April 14, 2021
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 MacrodomainXiaomin Ni, Martin Schröder, Vincent Olieric, et al.
Journal of Medicinal Chemistry|November 24, 2025
Structural Tuning of Partial RXR Agonism and AntagonismMax Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Communications Chemistry|July 1, 2024
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growingMinh Sai, Emily C Hank, Hin-Man Tai, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 ModulatorsAlisa Lang, Tanja Stiller, Niklas Ildefeld, et al.
Journal of Medicinal Chemistry|July 17, 2025
Carboxylic Acid Bioisosteres Boost Nurr1 Agonist SelectivityTanja Stiller, Christian Gege, Wael Saeb, et al.
Bioorganic Chemistry|September 26, 2022
Fragment-based discovery of orphan nuclear receptor Nur77/NGFI-B ligandsSilvia Arifi, Daniel Zaienne, Jan Heering, et al.
Food & Function|December 23, 2022
State-of-the-art methodological investigation of carotenoid activity and metabolism - from organic synthesis <i>via</i> metabolism to biological activity - exemplified by a novel retinoid signalling pathwayTorsten Bohn, Angel R de Lera, Jean-Francois Landrier, et al.
Journal of Medicinal Chemistry|July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer PreferenceFelix Nawa, Arthur Kardanov, Till Kasch, et al.
Journal of Medicinal Chemistry|September 4, 2020
Photohormones Enable Optical Control of the Peroxisome Proliferator-Activated Receptor γ (PPARγ)Konstantin Hinnah, Sabine Willems, Johannes Morstein, et al.
Bioorganic & Medicinal Chemistry|May 3, 2015
Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like propertiesDaniel Flesch, Matthias Gabler, Andreas Lill, et al.
ACS Medicinal Chemistry Letters|April 14, 2021
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 MacrodomainXiaomin Ni, Martin Schröder, Vincent Olieric, et al.
Journal of Medicinal Chemistry|November 24, 2025
Structural Tuning of Partial RXR Agonism and AntagonismMax Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.
Pageof 17